The second-line management of idiopathic overactive bladder: what is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?
作者信息
Chapple Christopher, De Ridder Dirk
机构信息
Sheffield Teaching Hospital NHS Trust, Royal Hallamshire Hospital, Sheffield, UK.
出版信息
BJU Int. 2009 Nov;104(9):1188-90. doi: 10.1111/j.1464-410X.2009.08777.x. Epub 2009 Aug 13.
Abstract
摘要
相似文献
1
The second-line management of idiopathic overactive bladder: what is the place of sacral neuromodulation and botulinum toxin-A in contemporary practice?特发性膀胱过度活动症的二线治疗：在当代临床实践中，骶神经调节和A型肉毒杆菌毒素的地位如何？
BJU Int. 2009 Nov;104(9):1188-90. doi: 10.1111/j.1464-410X.2009.08777.x. Epub 2009 Aug 13.
2
[Neuromodulation as a treatment for overactive bladder syndrome].[神经调节作为膀胱过度活动症的一种治疗方法]
Ned Tijdschr Geneeskd. 2012;156(33):A4135.
3
[Update on the second line management of idiopathic overactive bladder].[特发性膀胱过度活动症二线治疗的最新进展]
Prog Urol. 2009 Sep;19(8):530-7. doi: 10.1016/j.purol.2009.02.001. Epub 2009 Mar 19.
4
Current information on sacral neuromodulation and botulinum toxin treatment for refractory idiopathic overactive bladder syndrome: a review.骶神经调节和肉毒杆菌毒素治疗难治性特发性膀胱过度活动症的最新信息：综述
Urol Int. 2010;84(3):245-53. doi: 10.1159/000288223. Epub 2010 Apr 13.
5
Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.初始肉毒毒素治疗后特发性逼尿症患者的骶神经调节。
J Urol. 2013 Dec;190(6):2148-52. doi: 10.1016/j.juro.2013.07.017. Epub 2013 Jul 17.
6
Editorial comment on: histological changes in the urothelium and suburothelium of human overactive bladder following intradetrusor injections of botulinum neurotoxin type A for the treatment of neurogenic or idiopathic detrusor overactivity.关于“肉毒杆菌神经毒素A膀胱逼尿肌内注射治疗神经源性或特发性逼尿肌过度活动后人类膀胱过度活动症患者尿路上皮及尿路上皮下组织的组织学变化”的编辑评论
Eur Urol. 2008 Jun;53(6):1253. doi: 10.1016/j.eururo.2008.02.038. Epub 2008 Mar 7.
7
Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence.骶神经调节与膀胱内注射A型肉毒毒素治疗难治性急迫性尿失禁的成本效益
J Urol. 2009 Dec;182(6):2799-804. doi: 10.1016/j.juro.2009.08.031. Epub 2009 Oct 17.
8
The case for bladder botulinum toxin application.膀胱肉毒杆菌毒素应用的情况
Urol Clin North Am. 2006 Nov;33(4):503-10, ix. doi: 10.1016/j.ucl.2006.06.010.
9
Re: Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.回复：关于100例对抗胆碱能药物难治的特发性膀胱过度活动症患者行肉毒杆菌A毒素膀胱逼尿肌注射的经验
J Urol. 2007 Feb;177(2):796-7; author reply 797. doi: 10.1016/j.juro.2006.09.089.
10
Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder.骶神经调节和膀胱内肉毒毒素治疗难治性膀胱过度活动症。
Curr Opin Obstet Gynecol. 2012 Oct;24(5):331-6. doi: 10.1097/GCO.0b013e3283573ff9.
引用本文的文献
1
Voiding dysfunction in the female patient: is the "syndrome" paradigm valid?女性排尿功能障碍：“综合征”范式是否有效？
Curr Urol Rep. 2011 Oct;12(5):377-80. doi: 10.1007/s11934-011-0207-z.
2
Role of botulinum toxin-A in refractory idiopathic overactive bladder patients without detrusor overactivity.A型肉毒毒素在无逼尿肌过度活动的难治性特发性过度活动膀胱患者中的作用。
Int Urol Nephrol. 2012 Feb;44(1):91-7. doi: 10.1007/s11255-011-9979-9. Epub 2011 Jun 4.
3
The surgical management of the refractory overactive bladder.难治性膀胱过度活动症的外科治疗
Indian J Urol. 2010 Apr;26(2):263-9. doi: 10.4103/0970-1591.65402.
4
The use of botulinum toxin a in idiopathic overactive bladder syndrome.A型肉毒毒素在特发性逼尿肌过度活动症中的应用。
Curr Urol Rep. 2010 Sep;11(5):353-9. doi: 10.1007/s11934-010-0134-4.
5
What is the predictive value of urodynamics to reproduce clinical findings of urinary frequency, urge urinary incontinence, and/or stress urinary incontinence?尿动力学检查对于重现尿频、急迫性尿失禁和/或压力性尿失禁的临床症状有何预测价值？
Int Urogynecol J. 2010 Oct;21(10):1205-9. doi: 10.1007/s00192-010-1180-7. Epub 2010 Jun 18.
Zotero 插件